Recent

% | $
Quotes you view appear here for quick access.

Insmed Incorporated Message Board

  • johnmatson6l johnmatson6l Apr 7, 2014 10:19 AM Flag

    Insmed Down on Disappointing Arikayce Results Zacks By Zacks Equity Research

    Insmed Down on Disappointing Arikayce Results
    Zacks By Zacks Equity Research
    r the company announced that its candidate, Arikayce, failed to meet the primary objective in a phase II study (n=90). The candidate is being developed for the treatment of patients suffering from treatment resistant nontuberculous mycobacterial (:NTM) lung infections.

    The primary objective of the phase II study was a semi-quantitative measurement of the difference in mycobacterial density on a seven-point scale from baseline to the end of the randomized portion of the study

 
INSM
12.55+0.22(+1.78%)2:08 PMEST